Press Releases Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles Other stock markets 11:55:00 2026-01-22 am EST			5-day change	1st Jan Change
0.1710 ^EUR	-3.39%		-2.29%	+0.59%

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

Press Releases

25-09-29	Celyad Oncology : Announces Research Facility Divestiture	PU
25-09-12	Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC	AQ
25-09-11	Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	PU
25-08-13	Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC	PU
25-07-28	Celyad Oncology : Announces €1 Million Private Placement	PU
25-06-24	Celyad Oncology : Announces Strategic Review	PU
25-05-22	Celyad Oncology : AGM Minutes - informal translation ENG	PU
25-04-18	Celyad Oncology : Annual Report 2024 ENG	PU
25-04-18	Celyad Oncology : Report of the Statutory Auditor on the Consolidated Annual Account 2024 ENG	PU
25-04-18	Celyad Oncology : Information Note to Shareholders ENG	PU
25-04-02	Celyad Oncology : Reports Full Year 2024 Financial Results and Recent Business Highlights	PU
25-02-18	Celyad Oncology : announces the publication of the preclinical and clinical data of CYAD 211 providing proof of concept of its miRNA based shRNA platform	PU
24-10-31	Celyad Oncology : Articles of Association informal version EN	PU
24-10-31	Celyad Oncology : Information to the Shareholders - EN	PU
24-10-08	Celyad Oncology to Present at the 2024 SITC Annual Meeting	AQ
24-04-05	Celyad Oncology reports full year 2023 financial results and recent business highlights	AQ
24-04-05	Celyad Oncology : Report of the Statutory Auditor on the Consolidated Annual Account 2023 ENG	PU
24-01-16	Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook	AQ
23-12-20	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	AQ
23-12-04	Celyad announces management change	AQ
23-12-01	Celyad Oncology : announces management change	PU
23-11-24	Celyad Oncology : reports third quarter 2023 financial results and recent business highlights - Form 6-K	PU
23-11-22	Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC	AQ
23-11-21	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	AQ
23-11-21	Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 22 DECEMBER 2023 - Form 6-K	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Press Releases

Filters